Related references
Note: Only part of the references are listed.Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?
Benoit Haelewyn et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Clot Retrieval for Stroke Should Be Restricted to Clinical Trials No
Anthony J. Furlan
STROKE (2010)
Glibenclamide Is Superior to Decompressive Craniectomy in a Rat Model of Malignant Stroke
J. Marc Simard et al.
STROKE (2010)
Use of Telemetry Blood Pressure Transmitters to Measure Intracranial Pressure (ICP) in Freely Moving Rats
Gergely Silasi et al.
CURRENT NEUROVASCULAR RESEARCH (2009)
Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage
J. Marc Simard et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke
J. Marc Simard et al.
STROKE (2009)
Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association
Gregory J. del Zoppo et al.
STROKE (2009)
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Marc Fisher et al.
STROKE (2009)
Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke
Yoshihiro Murata et al.
STROKE (2008)
Dissolution test for glibenclamide tablets
Elisabeth Aparecida dos Santos Gianotto et al.
QUIMICA NOVA (2007)
Endothelial sulfonylurea receptor 1-regulated NCCa-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury
J. Marc Simard et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia
Mushfiquddin Khan et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Comparison of silicon-coated nylon suture to plain nylon suture in the rat middle cerebral artery occlusion model
Norihito Shimamura et al.
JOURNAL OF NEUROSCIENCE METHODS (2006)
Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke
JM Simard et al.
NATURE MEDICINE (2006)
Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window
YM Yu et al.
STROKE (2005)
Recovery from ischemic brain injury in the rat following a 10 h delayed injection with MLN519
AJ Williams et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Delayed treatment of ischemia/reperfusion brain injury - Extended therapeutic window with the proteosome inhibitor MLN519
AJ Williams et al.
STROKE (2004)
Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension - Novel mechanism for nitrate tolerance in vascular smooth muscle
V Gerzanich et al.
CIRCULATION RESEARCH (2003)
Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique
H Yamamoto et al.
EXPERIMENTAL NEUROLOGY (2003)
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke
L Zhang et al.
CIRCULATION (2003)
Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model
SC Fagan et al.
NEUROLOGICAL RESEARCH (2003)
Kinetics of proton transport in water
AA Kornyshev et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2003)
Influence of different fixation procedures on the quantification of infarction and oedema in a rat model of stroke
K Overgaard et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Share Paper
